The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...

Shortly after sunrise, John Gobbi stepped gingerly across a sidewalk in Boston’s South End strewn with dirty and discarded drug needles. Every so often his work boots crushed another syringe ...

What Is a Derma Roller? A derma roller is a small handheld device consisting of tiny needles. “These needles create micro-punctures in the skin. It was originally developed for skincare ...

WASHINGTON (AP) — Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and ...

Corbis / Corbis via Getty Images Medicare will negotiate prices for Ozempic and 14 other drugs in 2025, with prices taking effect in 2026. Negotiations could lower prices for Medicare ...

Drugs like Ozempic and Wegovy, called GLP-1 agonists, carry more benefits than risks when taken for their approved uses, according to a comprehensive analysis of their effects on 175 conditions.

Novo Nordisk's GLP-1 weight loss drugs, Ozempic and Wegovy, will be targeted in the next round of Medicare price negotiations in 2027, along with 13 other medications.Seana Smith and Brad Smith ...

Popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers, the Biden ...

Drugs like Ozempic and Wegovy were already off to fast starts because of their ability to help treat Type 2 diabetes and improve weight loss for millions of Americans. But a new study suggests ...

Blockbuster diabetes drug Ozempic is on the list. That means the federal government and the pharmaceuticals industry are about to go head-to-head once again. The Centers for Medicare and Medicaid ...

But now, weight-loss drugs like Ozempic and Wegovy are dominating the conversation ... Before we pin all our hopes on a needle, let’s remember: in a country where many are already struggling with ...